UK markets closed

Tiziana Life Sciences PLC (TLSA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.4900+0.0800 (+3.32%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5202.64M
Enterprise value 3177.02M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)3.88
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-5.82

Trading information

Stock price history

Beta (5Y monthly) -0.10
52-week change 35.83%
S&P500 52-week change 338.51%
52-week high 312.1700
52-week low 31.7600
50-day moving average 32.3985
200-day moving average 32.8124

Share statistics

Avg vol (3-month) 3386.14k
Avg vol (10-day) 3267.11k
Shares outstanding 597.31M
Implied shares outstanding 6N/A
Float 45.24M
% held by insiders 10.00%
% held by institutions 113.25%
Shares short (27 May 2021) 4106.04k
Short ratio (27 May 2021) 40.4
Short % of float (27 May 2021) 4N/A
Short % of shares outstanding (27 May 2021) 40.11%
Shares short (prior month 29 Apr 2021) 4126.93k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 330 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.05%
Return on equity (ttm)-91.89%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -30.41M
Net income avi to common (ttm)-26.13M
Diluted EPS (ttm)-0.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)65.82M
Total cash per share (mrq)0.68
Total debt (mrq)555k
Total debt/equity (mrq)0.89
Current ratio (mrq)8.79
Book value per share (mrq)0.64

Cash flow statement

Operating cash flow (ttm)-11.34M
Levered free cash flow (ttm)-2.58M